Sessions (2024)
90
Medicare patients
15
CMS floor count
Sessions per patient
6.0–6.0
peer average 9.3
Est. Medicare paid
$65,767
peer median $124,239
Label compliance
The FDA esketamine label allows roughly 34 sessions per patient in a year when dosing is tapered; 56 is the ceiling for never tapering anyone, and 70 implies twice-weekly maintenance all year. This provider ranks #41 of 76 Medicare providers billing Spravato in 2024, and accounts for 0.48% of national Medicare Part B Spravato payment.
No flags — sessions per patient sit inside the label range.
CMS billing by year
| Year | Patients | Sessions | Sessions / patient | 84mg share | Medicare paid | Rank | Risk |
|---|---|---|---|---|---|---|---|
| 2024 | 15 | 90 | 6.0–6.0 | 100% | $65,767 | #41 of 76 | Risk 5 · Low |
Source: CMS Medicare Physician & Other Practitioners by Provider and Service, HCPCS G2082 and G2083, aggregated by rendering NPI. Medicare fee-for-service only — Medicare Advantage and Part D are not included. CMS suppresses provider-code rows with fewer than 11 beneficiaries. Sessions per patient is a calendar-year ratio shown as a range because CMS counts beneficiaries per code. These figures are a screening signal built from public data, not an audit finding or an allegation of wrongdoing.
Build the list for one county and see whether the names are right.
Ask in plain language. RepVector finds the universe, enriches each target from its own website, scores it 0–100, and hands you a ranked call list with phones, addresses and named contacts.
3 free runs — no card required.